ERIKA PINTO: Open Payments
NPI 1164977013 · BERLIN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,974 in 125 payments from 18 companies in 2025. Trend: 2023 $2,126 · 2024 $3,048 · 2025 $2,974
Food & beverage: $2,974
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $761 |
| Janssen Biotech, Inc. | 14 | $469 |
| QOL Medical, LLC | 17 | $391 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $227 |
| Phathom Pharmaceuticals, Inc. | 13 | $170 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $162 |
| GENZYME CORPORATION | 6 | $151 |
| Regeneron Healthcare Solutions, Inc. | 7 | $149 |
| Ardelyx, Inc. | 4 | $79 |
| PFIZER INC. | 4 | $65 |
Products named: TREMFYA, Sucraid, DUPIXENT, MAVYRET, SKYRIZI, ENTYVIO, VOQUEZNA, XIFAXAN.
Industry payments across MD — which companies pay providers there.
